SASagar Acharya

Sagar Acharya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sagar Acharya has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Editorial: CNS immunity – paradox of maintenance, repair and destruction

    by Anirban Ghosh, Roman Sankowski, Sagar Acharya, Karen Bohmwald

    Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, microglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense (Couper et...

  • Open Access

    Editorial: CNS immunity – paradox of maintenance, repair and destruction

    by Anirban Ghosh, Roman Sankowski, Sagar Acharya, Karen Bohmwald

    Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, icroglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer viewed in isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense...